Skip to main content

Table 3 Univariate and multivariate analyses in the low MMV group

From: Automated evaluation of masseter muscle volume: deep learning prognostic approach in oral cancer

Variables

 

Univariate analysis

 

Multivariate analysis

 

(Fisher’s exact test)

(Cox proportional hazards model)

Cutoff

HR

p-value

HR

p-value

(95% CI)

(95% CI)

Age

77

2.018

0.068

  

(0.919–4.268)

  

Sex

Male or female

0.927

0.871

  

(0.468–1.857)

  

Stage

I and II or III and IV

10.875

< 0.001

5.631

< 0.001

(4.714–28.304)

(2.477–12.800)

CRP (mg/dL)

1.15

3.259

0.021

0.659

0.501

(1.044–9.314)

(0.196–2.220)

Alb (g/dL)

4.3

2.090

0.035

0.582

0.183

(1.041–4.329)

(0.262–1.292)

A/G ratio

1.58

3.015

0.004

1.249

0.617

(1.315–7.802)

(0.522–2.987)

T-cho (mg/dL)

143

1.504

0.510

  

(0.349–4.984)

  

mGPS

2

12.550

0.005

2.516

0.238

(1.736–143.109)

(0.543–11.650)

CONUT

2

4.682

< 0.001

1.872

0.094

(2.143–10.115)

(0.898–3.904)

CAR

0.033

2.703

0.065

  

(0.920–10.839)

  

NLR

2.398

2.676

0.003

1.028

0.939

(1.337–5.496)

(0.502–2.108)

PLR

189.51

1.493

0.263

  

(0.688–3.114)

  

PNI

53.888

3.428

0.005

1.857

0.273

(1.371–10.281)

(0.615–5.609)

BMI (kg/m2)

20.233

3.375

< 0.001

2.055

0.022

(1.680–6.959)

(1.108–3.812)

MMV (cm3)

Male, 45.030

 

< 0.001

 

< 0.001

8.789

4.325

Female, 31.752

(4.078–20.350)

(2.082–8.981)

  1. Low MMV was an independent poor prognostic factor, along with stage and BMI (HR, 4.325; 95% CI, 2.082–8.981; p < 0.001)